TrialBone marrow transplantation2019

Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation.

Michelle Schoettler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.